Retail and clinics Leverage binx io’s CLIA-waived, FDA-cleared rapid PCR testing to pursue partnerships with retail clinics, supermarkets, and primary care offices seeking convenient, on-site diagnostic capabilities.

Strategic distribution Capitalize on existing distribution deals and investors to expand reach through Fisher Healthcare (Thermo Fisher), McKesson, and other healthcare distributors to scale availability of on-demand testing nationwide.

Home testing growth Target direct-to-consumer at-home testing channels given prior acquisitions and consumer-facing platforms; position for upsell of follow-up care and at-home sampling kits from an integrated ecosystem.

Partnerships leverage Explore co-development or co-branding with PHI/health insurers and pharmaceutical distributors (e.g., Wellfleet, Mark Cuban Cost Plus Drug Company) to expand access and reimbursement coverage for rapid multiplex testing.

Global expansion Identify opportunities in international markets, leveraging UK Bath presence and global investors to deploy io platforms in neighboring regions, while aligning with local regulatory pathways and multi-plex capabilities.